0002070013-25-000001.txt : 20250612 0002070013-25-000001.hdr.sgml : 20250612 20250612114921 ACCESSION NUMBER: 0002070013-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250612 DATE AS OF CHANGE: 20250612 EFFECTIVENESS DATE: 20250612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SV8 Biotech Fund LP CENTRAL INDEX KEY: 0002070013 ORGANIZATION NAME: EIN: 981846114 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-548769 FILM NUMBER: 251042133 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 71 KINGSWAY CITY: LONDON PROVINCE COUNTRY: X0 ZIP: WC2B 6ST BUSINESS PHONE: 44 20 7421 7081 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 71 KINGSWAY CITY: LONDON PROVINCE COUNTRY: X0 ZIP: WC2B 6ST D 1 primary_doc.xml X0708 D LIVE 0002070013 SV8 Biotech Fund LP 71 KINGSWAY LONDON X0 UNITED KINGDOM WC2B 6ST 44 20 7421 7081 UNITED KINGDOM None None Limited Partnership true 2025 - SV Health Managers LLP 71 Kingsway London X0 UNITED KINGDOM WC2B 6ST Executive Officer Director Promoter Manager of Issuer - SV8 Bio GP LLP 71 Kingsway London X0 UNITED KINGDOM WC2B 6ST Executive Officer Director General Partner of Issuer James Costine 71 Kingsway London X0 UNITED KINGDOM WC2B 6ST Executive Officer CFO - UK of the Manager Kate Bingham 71 Kingsway London X0 UNITED KINGDOM WC2B 6ST Executive Officer Managing Partner of Manager Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true true false 0 Northern Lights Alternative Advisors LLP None Foreside Global Services, LLC 147382 Rex House 4-12 Regent Street London X0 UNITED KINGDOM SW1Y 4PE All States false Indefinite 0 Indefinite false 0 0 true 0 Northern Lights operates under exemption from U.S. broker-dealer registration set forth in SEC Rule 15a-6, with Foreside Global Services, LLC, a U.S. broker-dealer registered with the SEC providing Chaperoning Services to Northern Lights for this Fund. 0 true The Manager will receive a Management Fee as described in the offering documents. This amount is indeterminable at this time. false SV8 Biotech Fund LP James Costine James Costine CFO - UK of the Manager 2025-05-09